Treating co-occurring mental health and addiction during COVID-19: Considerations for telehealth

This is the first in a series of two live, interactive webinar presentations (90 minutes each) which will focus how to best treat adolescents and adults with co-occurring mental health and addiction during the COVID-19 pandemic. Designed for intermediate practitioners, this presentation will highlight core principles of providing telehealth services during the pandemic. Discussion topics will also include treatment factors that impact this population, the differing risks associated with virtual care, and how assessing risk may be different when conducting telehealth. Ample time will be allotte...Read mored at the end of the presentation to address audience questions Less...

Register for this Webinar

Learning Objectives

  • Explain three factors that need to be considered when conducting telehealth with someone who has a substance use disorder.
  • Identify two increased risks associated specifically with conducting telehealth with the substance use disorder population as a result of COVID-19.
  • Identify two reasons for conducting a risk assessment with a substance use disorder patient via telehealth.

Learning Levels

  • Intermediate

Thursday, June 11, 2020

Live Interactive Webinar

01:00 PM EDT - 02:30 PM EDT

Register for this Webinar
EARN 1.5 CE Credit Hours

About the speakers

Gabrielle Jones, PhD

Gabrielle Jones, PhD

Clinical Supervisor, San Francisco East Bay
Gabrielle Jones, PhD, is a licensed clinical psychologist and clinical supervisor at Rogers Behavioral Health’s San Francisco East Bay location who specializes in treating adolescents and adults with mental health and co-occurring disorders. Dr. Jones serves on the California Psychological Association (CPA) board, the American Psychological Association’s (APA) membership board, and as an associate member for the American Society of Addiction Medicine (ASAM).
Sean LeNoue, MD

Sean LeNoue, MD

Associate Medical Director, Outpatient Services
Dr. LeNoue is a child/adolescent, adult, and addiction psychiatrist who serves as an associate medical director of outpatient services for the northern and eastern service area at Rogers. He specializes in the treatment of co-occurring mental health and substance use disorders. Dr. LeNoue is a member of the American Academy of Child and Adolescent Psychiatry (AACAP), American Psychiatric Association (APA), American Society of Addiction Medicine (ASAM), and the American Academy of Addiction Psychiatry (AAAP).
Michelle Maloney, PhD, LPC, NCSE, CAADC, CRPS

Michelle Maloney, PhD, LPC, NCSE, CAADC, CRPS

Executive Director of Addiction Recovery Services
Dr. Maloney serves as executive director of Addiction Services for Rogers Behavioral Health. She has more than two decades of experience in the mental health and addiction fields as a licensed professional counselor and nonprofit leader. Dr. Maloney earned a doctorate in Leadership from Alvernia University in Reading, Pennsylvania, and has specialty certifications as a national clinical supervision endorsement by the National Association for Addiction Professionals, and as a certified advanced alcohol and drug counselor and certified relapse prevention specialist. She completed a term as president of the Wisconsin International Certification and Reciprocity Certification (ICRC) chapter, in addition to a term on the Pennsylvania ICRC board, and is currently serving on the addiction treatment and quality committee for the National Association for Behavioral Healthcare.

CE Information - Earn 1.5 CE Credit Hours

CE Approvals

American Psychological Association
Rogers Behavioral Health is approved by the American Psychological Association to sponsor continuing education for psychologists. Rogers Behavioral Health maintains responsibility for this program and its content. Rogers Behavioral Health designates this live program for X continuing education credits; no partial credits will be awarded.
Association of Social Work Boards
Rogers Behavioral Health, provider number 1101, is approved as a provider for social work continuing education by the Association of Social Work Boards (ASWB), www.aswb.org, through the Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved as ACE providers. State and provincial regulatory board have the final authority to determine whether an individual course may be accepted for continuing education credit. Rogers Behavioral Health maintains responsibility for this course. Approval period: October 18, 2023 – October 18, 2026. Social workers completing this course receive X clinical continuing education credits.
National Board for Certified Counselors
Rogers Behavioral Health has been approved by NBCC as an Approved Continuing Education Provider, ACEP No. 6192. Programs that do not qualify for NBCC credit are clearly identified. Rogers Behavioral Health is solely responsible for all aspects of the programs. X instructional clock hours will be awarded.
Other Professionals
Rogers Behavioral Health will issue a certificate of attendance for your participation in this activity.

CE Process Info

A Continuing Education Certificate for this program will be obtained using the website CE Go. After the event, you will receive an email with a link to CE Go. This link will be emailed to the account you used to register for this event.

Upon accessing the CE-Go website, you will be able to:

  • Complete the mandatory evaluation form
  • Download your CE Certificate in PDF form

AGENDA

1 pm ET Welcome and speaker introductions

1:05 pm Overview of challenges in treating mental health and addiction disorders during COVID-19

                     • Substance use disorder stigma

                     • Virtual intake differences and limitations

                     • Home environment considerations

1:25 pm Considerations for conducting telehealth treatment

                     • Evidence-based treatment options

                     • Logistics of providing care in a virtual world

1:40 pm Challenges associated with treating mental health and addiction disorders during COVID-19

                     • Isolation and risk for overdose

                     • Engaging tech-savvy youth

                     • Drug screening

1:55 pm Assessment of patient needs and risk factors

                     • Vulnerable populations need extra support now more than ever

                     • Increased access to substances

                     • Development of new/worsening mental health and addiction-related issues due to stressors associated with the pandemic

2:15 pm Moderated Q&A

2:30 pm Where to get additional information on this topic